Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 269
interventional 158
Observational 99
Registry 12

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 84
Drug|placebo 22
Biological 14
Other 9
Procedure 8
Device 5
Behavioral 3
Biological|Drug 3
Diagnostic Test 3
Device|Drug 2
Drug|Other 2
Device|Other 1
Drug|placebo|Procedure 1
Genetic 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 25
France 11
NA 8
United Kingdom 8
Brazil 6
Canada 5
Japan 5
Germany 4
China 3
Spain 3
India 2
Israel 2
Korea, Republic of 2
United States|Israel|United Kingdom 2
Australia 1
Australia|Austria|Belgium|Canada|Denmark|Finland|Germany|Italy|Netherlands|Norway|Singapore|Spain|Sweden|Switzerland|United Kingdom 1
Australia|Austria|Canada|France|Germany|Israel|Singapore|South Africa|United Kingdom 1
Australia|Belgium|Canada|Denmark|France|Germany|Ireland|Italy|Netherlands|Spain|United Kingdom 1
Australia|Canada|France|Germany|Spain|Sweden|United Kingdom 1
Australia|Denmark|Finland|Germany|Italy|Singapore|Spain|Taiwan|United Kingdom 1
Australia|New Zealand 1
Austria|Belgium|China|Germany|Hong Kong|Italy|Netherlands|Portugal|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
Austria|Czech Republic|Denmark|Finland|France|Germany|Hong Kong|Italy|Poland|Spain|Taiwan|United Kingdom 1
Austria|Denmark|Germany|Italy|Malaysia|South Africa|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
Belgium|Germany|Poland|Spain|Switzerland 1
Bulgaria|United States|Belarus|Romania|Russian Federation|Ukraine 1
Canada|Finland|Germany|India|Israel|Italy|Netherlands|Singapore|Spain|Switzerland|Taiwan 1
China|Taiwan|Thailand 1
Denmark 1
Denmark|Germany|Netherlands|Norway|United Kingdom 1
Egypt 1
Finland 1
France|Germany|Israel 1
France|Hungary|Israel|Poland|Spain|Turkey|United Kingdom 1
France|South Africa|United Kingdom 1
Germany|Greece|Italy|Spain|United Kingdom 1
Germany|Israel|Italy|Spain|Switzerland 1
Germany|Japan|Spain 1
Germany|Latvia|Malaysia|Spain 1
Japan|United States|Australia|Brazil|Canada|Croatia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Lithuania|Malaysia|Netherlands|Norway|Portugal|Puerto Rico|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
Lithuania 1
Malaysia|Philippines|Thailand 1
Malaysia|United Kingdom 1
Netherlands 1
Portugal 1
Singapore|United States|Canada|Italy 1
Spain|Sweden|United States|Austria|Canada|Croatia|Denmark|Greece|Israel|Italy|Japan|Malaysia|Ukraine|United Kingdom 1
Sweden 1
Switzerland 1
Turkey 1
United States|Algeria|Argentina|Australia|Austria|Bulgaria|Canada|France|Germany|Greece|Israel|Italy|Japan|Malaysia|Romania|Spain|Taiwan|Thailand 1
United States|Algeria|Argentina|Australia|Austria|Canada|France|Germany|Israel|Italy|Japan|Malaysia|Netherlands|Spain|Taiwan|Thailand|United Kingdom 1
United States|Algeria|Austria|Brazil|China|Denmark|Greece|Hong Kong|Hungary|Japan|Lithuania|Poland|Portugal|Puerto Rico|Russian Federation|Serbia|Spain|Turkey 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Croatia|Czechia|Finland|France|Germany|Hungary|India|Israel|Korea, Republic of|Netherlands|New Zealand|Peru|Russian Federation|Serbia|Spain|Taiwan|United Kingdom 1
United States|Argentina|Austria|Croatia|Denmark|Germany|Hong Kong|India|Indonesia|Israel|Italy|Norway|Pakistan|Poland|Serbia|South Africa|Spain|Sweden|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Argentina|Brazil|Bulgaria|France|Philippines|Poland|Romania|Russian Federation|South Africa|Spain|Turkey 1
United States|Argentina|Brazil|Canada|Croatia|France|Hungary|Israel|Italy|Japan|Malaysia|Poland|South Africa|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Croatia|Denmark|Finland|France|Germany|Hong Kong|Israel|Italy|Netherlands|Norway|Singapore|Spain|Sweden|Switzerland|Taiwan|Thailand 1
United States|Australia|Austria|Croatia|France|Germany|Israel|Malaysia|Netherlands|Poland|Spain|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Austria|Denmark|Finland|France|Germany|Israel|Italy|Poland|Singapore|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
United States|Australia|Brazil|Bulgaria|Croatia|Denmark|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Malaysia|Netherlands|Norway|Puerto Rico|Russian Federation|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Australia|Brazil|Bulgaria|Croatia|Denmark|France|Germany|Hungary|Israel|Italy|Japan|Malaysia|Netherlands|Norway|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Austria|Brazil|Croatia|Greece|Hungary|Italy|Japan|Malaysia|Poland|Puerto Rico|Romania|Russian Federation|Serbia|South Africa|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Austria|Bulgaria|Germany|Serbia|Spain|Taiwan 1
United States|Austria|Canada|Finland|France|Germany|Israel|Italy|Japan|Spain|Switzerland|United Kingdom 1
United States|Austria|Canada|Finland|France|Germany|Israel|Italy|Spain|Switzerland|United Kingdom 1
United States|Austria|France|Germany|Greece|Italy|Japan|Macedonia, The Former Yugoslav Republic of|Malaysia|Netherlands|Romania|Russian Federation|South Africa|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Austria|France|Germany|Greece|Italy|Japan|Macedonia, The Former Yugoslav Republic of|Malaysia|Netherlands|Romania|South Africa|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Austria|France|Germany|Japan|Serbia 1
United States|Belarus|Bulgaria|Lebanon|Romania|Russian Federation 1
United States|Brazil|Canada|Croatia|France|Germany|Italy|Japan|Malaysia|Taiwan|United Kingdom 1
United States|Brazil|Canada|France|Greece|Israel|Italy|Japan|Lithuania|Malaysia|Portugal|Puerto Rico|Switzerland|Turkey|Ukraine|United Kingdom 1
United States|Brazil|Croatia|Denmark|Former Serbia and Montenegro|Germany|Hungary|Israel|Italy|Japan|Malaysia|Russian Federation|Serbia|Spain|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Brazil|Croatia|Germany|Israel|Italy|Japan|Latvia|Lithuania|Macedonia, The Former Yugoslav Republic of|Malaysia|Poland|Puerto Rico|Russian Federation|Serbia|Spain|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Brazil|Former Serbia and Montenegro|France|Japan|Malaysia|Serbia|South Africa|Sweden|Turkey|United Kingdom 1
United States|Brazil|Italy|Japan|Lithuania|Macedonia, The Former Yugoslav Republic of|Malaysia|Poland|Puerto Rico|Russian Federation|Serbia|Taiwan|Turkey 1
United States|Canada 1
United States|Canada|Denmark|Germany|Israel|Italy|Japan|Spain|Sweden|United Kingdom 1
United States|Canada|Denmark|Germany|United Kingdom 1
United States|Canada|France|Germany|Hungary|Italy|Japan|Macedonia, The Former Yugoslav Republic of|Malaysia|Netherlands|Russian Federation|South Africa|Thailand|Turkey|United Kingdom 1
United States|Denmark|France|Germany|Japan|Spain|Sweden|United Kingdom 1
United States|Denmark|France|Germany|Netherlands|Spain 1
United States|Denmark|France|United Kingdom 1
United States|Germany|Italy|Japan|Switzerland|Turkey|United Kingdom 1
United States|Germany|Switzerland 1
United States|Greece|Japan|Malaysia|Romania|Serbia|Thailand 1

Sites per Study

Site_count Study_Count
1 71
2 5
3 5
4 4
5 2
6 2
7 5
8 2
9 3
10 2
11 2
12 1
13 2
14 3
15 6
16 1
18 4
19 2
20 1
22 2
24 1
25 1
30 1
32 2
33 1
34 2
35 1
37 2
38 1
41 1
43 1
44 1
45 1
46 1
49 1
51 1
52 1
57 1
59 1
61 1
63 1
64 1
66 1
69 2
70 2
93 1
161 1
167 1

Phase

Phase Study_Count
Phase 3 37
Phase 1 35
N/A 31
Phase 2 26
Phase 4 20
Phase 1/Phase 2 7
Phase 2/Phase 3 2

Number of Arms

Number_of_Arms Count_of_Studies
1 39
2 80
3 13
4 6
5 1
6 1
11 1
NA 17

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 4.0000 4.0 10.00000 4.0000 40.0 6.0000 15.0
1st Qu. 46.5000 15.0 25.00000 31.0000 67.5 57.5000 31.5
Median 80.0000 24.0 50.00000 60.0000 95.0 74.0000 44.0
Mean 182.4516 31.4 48.28571 124.8077 95.0 201.0833 139.9
3rd Qu. 108.0000 38.5 60.00000 186.5000 122.5 189.5000 155.0
Max. 1098.0000 160.0 108.00000 479.0000 150.0 1316.0000 1006.0

Trial Group Type

group_type Group_Count
Experimental 189
Active Comparator 50
Placebo Comparator 29
NA 17
No Intervention 10
Other 6

Intervention Model

intervention_model Study_Count
Parallel Assignment 89
Single Group Assignment 49
Crossover Assignment 15
Sequential Assignment 3
Factorial Assignment 1
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 124
Prevention 13
Diagnostic 10
Basic Science 3
Other 3
Supportive Care 2
Health Services Research 1
Screening 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 23
Japan 7
Switzerland 6
France 5
NA 5
Germany 4
China 3
Czechia 3
Korea, Republic of 3
Belgium 2
Brazil 2
Greece 2
India 2
Italy 2
Spain 2
Turkey 2
United States|Canada 2
Algeria|Austria|Belgium|Czech Republic|France|Germany|Italy|Netherlands|Poland|Portugal|Saudi Arabia|South Africa|Sweden|Turkey|United Kingdom|Venezuela 1
Algeria|Morocco|Oman|Saudi Arabia|United Arab Emirates 1
Argentina|Austria|Belgium|France|Germany|Hungary|Iran, Islamic Republic of|Ireland|Italy|Poland|Portugal|Slovakia|Sweden|United Kingdom 1
Austria 1
Canada|Spain|United Kingdom 1
Croatia|Czechia|Estonia|Germany|Greece|Israel|Spain|Sweden 1
Denmark 1
Finland 1
Hungary 1
India|Morocco|Oman|South Africa 1
Israel 1
Mexico 1
Mexico|Venezuela 1
Netherlands 1
Slovakia 1
Thailand 1
United Kingdom 1
United States|Algeria|Austria|Belgium|Bulgaria|France|Germany|Hungary|Italy|Netherlands|Pakistan|Spain|Sweden|Switzerland|United Kingdom 1
United States|Argentina|Canada|Croatia|Czech Republic|France|Germany|Ireland|Italy|Slovakia|Spain|Sweden|Switzerland|United Kingdom 1
United States|Australia|Canada|Thailand 1
United States|Austria|Czechia|France|Germany|Greece|Hungary|Italy|Netherlands|Poland|Slovakia|Slovenia|Spain|Sweden|Switzerland 1
United States|Canada|Germany|United Kingdom 1
United States|Canada|Hungary|Italy|Spain|United Kingdom 1
United States|France|Germany|Greece|Hong Kong|India|Iran, Islamic Republic of|Israel|Italy|Pakistan|Serbia|Slovakia|Spain|Thailand|Turkey|Venezuela 1

Sites per Study

Site_count Study_Count
1 74
2 5
3 3
4 2
5 1
7 2
9 1
10 1
11 1
14 2
15 1
16 2
17 1
35 1
41 1
61 1

Enrollment Metrics

Measure Observational
Min 2.0000
1st Qu 38.0000
Median 86.0000
Mean 641.6392
3rd Qu 300.0000
Max 19200.0000

Observation Model

observational_model Study_Count
Cohort 62
Case-Only 9
Other 9
NA 9
Case-Control 8
Case Control 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 70
Retrospective 12
Cross-Sectional 10
NA 7

Registries

Studies by Country

Country Study_Count
Italy 4
United States 4
Spain 2
NA 1
Switzerland 1

Sites per Study

Site_count Study_Count
1 10
2 1
20 1

Enrollment Metrics

Measure Registries
Min 40.000
1st Qu 75.000
Median 200.000
Mean 1058.833
3rd Qu 1104.000
Max 5000.000

Registry Model

observational_model Study_Count
Cohort 6
Case-Control 3
Case-Only 1
Ecologic or Community 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 8
Cross-Sectional 2
Other 2

Follow-up

target_duration Study_Count
1 Day 2
10 Years 2
2 Years 2
5 Years 2
3 Days 1
3 Years 1
30 Days 1
5 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03821597 Sequential Compression Devices Effect on Fibrinolysis in Plastic Surgery Outpatients https://ClinicalTrials.gov/show/NCT03821597 Completed Swanson Center 2018-12-31
NCT03355742 XIENCE 28 Global Study https://ClinicalTrials.gov/show/NCT03355742 Completed Abbott Medical Devices 2019-10-24
NCT03304977 Patient’s Knowledge on Their Anticoagulating and Anti Platelet Treatment St Joseph’s Hospital) https://ClinicalTrials.gov/show/NCT03304977 Completed Groupe Hospitalier Paris Saint Joseph 2016-07-31
NCT03296033 Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin https://ClinicalTrials.gov/show/NCT03296033 Recruiting Wake Forest University Health Sciences 2022-06-30
NCT03196284 A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors https://ClinicalTrials.gov/show/NCT03196284 Completed Novo Nordisk A/S 2018-09-19
NCT03075670 A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B https://ClinicalTrials.gov/show/NCT03075670 Completed Novo Nordisk A/S 2017-12-08
NCT03011827 Thromboelastometry in Liver Transplantation https://ClinicalTrials.gov/show/NCT03011827 Recruiting Hospital Clinic of Barcelona 2022-09-30
NCT02994407 Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A https://ClinicalTrials.gov/show/NCT02994407 Completed Novo Nordisk A/S 2018-10-15
NCT02979158 Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass https://ClinicalTrials.gov/show/NCT02979158 Completed Umeå University 2018-01-24
NCT02972684 Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass https://ClinicalTrials.gov/show/NCT02972684 Completed Nantes University Hospital 2020-02-29
NCT02941354 Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A https://ClinicalTrials.gov/show/NCT02941354 Completed Novo Nordisk A/S 2017-06-20
NCT02920398 A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A https://ClinicalTrials.gov/show/NCT02920398 Completed Novo Nordisk A/S 2017-04-07
NCT02918045 Dental Extractions in Patients Under Dual Antiplatelet Therapy https://ClinicalTrials.gov/show/NCT02918045 Completed University of Sao Paulo General Hospital 2019-07-16
NCT02864875 Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibility Trial https://ClinicalTrials.gov/show/NCT02864875 Completed University of Sao Paulo General Hospital 2017-01-31
NCT02834130 Input of a Multidisciplinary Device to Accompany the Announce of Diagnosis for Young Children With Serious Constitutional Hemorrhagic Disease and Their Families https://ClinicalTrials.gov/show/NCT02834130 Completed Assistance Publique Hopitaux De Marseille 2016-04-30
NCT02777424 CPP Versus PFC to Correct Coagulation Disorders in Adult Neurosurgical Patients https://ClinicalTrials.gov/show/NCT02777424 Recruiting Fondation Ophtalmologique Adolphe de Rothschild 2021-07-21
NCT02750150 Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients https://ClinicalTrials.gov/show/NCT02750150 Completed University Hospital, Lille 2016-01-31
NCT02736812 Pre-hospital Administration of Lyophilized Plasma for Post-traumatic Coagulopathy Treatment (PREHO-PLYO) https://ClinicalTrials.gov/show/NCT02736812 Completed French Defence Health Service 2019-10-31
NCT02689232 TEG (Thromboelastography) Based Versus Conventional Coagulation Parameters Based Correction of Coagulopathy in Non Variceal Bleed. https://ClinicalTrials.gov/show/NCT02689232 Completed Institute of Liver and Biliary Sciences, India 2018-03-03
NCT02637427 Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures https://ClinicalTrials.gov/show/NCT02637427 Recruiting Rutgers, The State University of New Jersey 2020-04-30
NCT02622126 Colloid Pre-Loading on D-Dimer During Cesarean Section Under Spinal Anesthesia https://ClinicalTrials.gov/show/NCT02622126 Completed Assiut University 2016-07-31
NCT02601053 The Fear F8ctor Study - Does Fear Induce a Blood Curdling State? https://ClinicalTrials.gov/show/NCT02601053 Completed Leiden University Medical Center 2015-08-31
NCT02593877 Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy https://ClinicalTrials.gov/show/NCT02593877 Completed Queen Mary University of London 2018-07-03
NCT02541942 Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adeptâ„¢2 Trial https://ClinicalTrials.gov/show/NCT02541942 Completed Novo Nordisk A/S 2016-04-15
NCT02490787 Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects https://ClinicalTrials.gov/show/NCT02490787 Completed Novo Nordisk A/S 2016-10-14
NCT02457403 Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy: Rotational Thromboelastometry Versus Conventional Therapy https://ClinicalTrials.gov/show/NCT02457403 Completed Ohio State University 2018-11-30
NCT02362178 Thromboelastographic Guide for Blood Products in Cirrhotics https://ClinicalTrials.gov/show/NCT02362178 Completed University of Modena and Reggio Emilia 2014-08-31
NCT02352181 Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment. https://ClinicalTrials.gov/show/NCT02352181 Completed Hospices Civils de Lyon 2016-08-31
NCT02281201 Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects https://ClinicalTrials.gov/show/NCT02281201 Completed CSL Behring 2016-01-31
NCT02239146 Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass https://ClinicalTrials.gov/show/NCT02239146 Completed Novo Nordisk A/S 2008-01-31
NCT02238028 Short-term Cardiovascular Benefits of Wearing Particulate-filtering Respirators https://ClinicalTrials.gov/show/NCT02238028 Completed Fudan University 2014-10-31
NCT02203968 Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST) https://ClinicalTrials.gov/show/NCT02203968 Completed Sunnybrook Health Sciences Centre 2015-12-31
NCT02187120 Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study) https://ClinicalTrials.gov/show/NCT02187120 Recruiting Monash University 2021-01-31
NCT02141074 Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B https://ClinicalTrials.gov/show/NCT02141074 Recruiting Novo Nordisk A/S 2022-10-30
NCT02120300 Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders https://ClinicalTrials.gov/show/NCT02120300 Completed Gilead Sciences 2015-08-31
NCT02096523 Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder https://ClinicalTrials.gov/show/NCT02096523 Enrolling by invitation Hadassah Medical Organization 2021-05-31
NCT01288391 Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients https://ClinicalTrials.gov/show/NCT01288391 Completed Novo Nordisk A/S 2011-07-31
NCT01272206 Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT01272206 Completed Novo Nordisk A/S 2011-03-31
NCT02009033 Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery https://ClinicalTrials.gov/show/NCT02009033 Completed Rigshospitalet, Denmark 2013-04-30
NCT01916408 The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon https://ClinicalTrials.gov/show/NCT01916408 Completed Technische Universität München 2014-01-31
NCT01848002 Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01848002 Completed Novo Nordisk A/S 2003-08-31
NCT01847989 Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01847989 Completed Novo Nordisk A/S 2003-05-31
NCT01787552 A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF https://ClinicalTrials.gov/show/NCT01787552 Completed Novartis 2018-04-10
NCT01752725 Comparison of BiCision® Versus UltraCision® During Laparoscopic Supracervical Hysterectomy (LASH) https://ClinicalTrials.gov/show/NCT01752725 Completed University Hospital Tuebingen 2012-04-30
NCT01731600 A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A https://ClinicalTrials.gov/show/NCT01731600 Completed Novo Nordisk A/S 2014-09-15
NCT01692925 Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A https://ClinicalTrials.gov/show/NCT01692925 Completed Novo Nordisk A/S 2013-03-31
NCT01601613 Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever https://ClinicalTrials.gov/show/NCT01601613 Completed Novo Nordisk A/S 2002-11-30
NCT01601457 Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture Reconstruction https://ClinicalTrials.gov/show/NCT01601457 Completed Novo Nordisk A/S 2004-04-30
NCT01598831 Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy https://ClinicalTrials.gov/show/NCT01598831 Completed Asahi Kasei Pharma America Corporation 2018-04-05
NCT01590823 An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients https://ClinicalTrials.gov/show/NCT01590823 Completed Nova Scotia Health Authority 2012-09-30
NCT01589666 Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01589666 Completed Entegrion, Inc. 2016-09-09
NCT01588132 Anfibatide Phase 1 Clinical Trial in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01588132 Completed Lee’s Pharmaceutical Limited 2011-03-31
NCT01566786 Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage https://ClinicalTrials.gov/show/NCT01566786 Completed Novo Nordisk A/S 2002-10-31
NCT01563523 Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients https://ClinicalTrials.gov/show/NCT01563523 Completed Novo Nordisk A/S 2003-10-31
NCT01563471 Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01563471 Completed Novo Nordisk A/S 2002-07-31
NCT01563458 Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation https://ClinicalTrials.gov/show/NCT01563458 Completed Novo Nordisk A/S 2003-08-31
NCT01563445 Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage https://ClinicalTrials.gov/show/NCT01563445 Completed Novo Nordisk A/S 2003-03-31
NCT01562821 Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy https://ClinicalTrials.gov/show/NCT01562821 Completed Novo Nordisk A/S 2002-12-31
NCT01562587 Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State https://ClinicalTrials.gov/show/NCT01562587 Completed Novo Nordisk A/S 2003-05-31
NCT01562574 Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease https://ClinicalTrials.gov/show/NCT01562574 Completed Novo Nordisk A/S 2004-08-31
NCT01562158 Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01562158 Completed Novo Nordisk A/S 2003-10-31
NCT01561924 Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography https://ClinicalTrials.gov/show/NCT01561924 Completed Novo Nordisk A/S 2006-05-31
NCT01561417 Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT01561417 Completed Novo Nordisk A/S 2006-09-30
NCT01561391 Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery https://ClinicalTrials.gov/show/NCT01561391 Completed Novo Nordisk A/S 2004-05-31
NCT01555749 Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects https://ClinicalTrials.gov/show/NCT01555749 Completed Novo Nordisk A/S 2012-05-08
NCT01536496 Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma https://ClinicalTrials.gov/show/NCT01536496 Completed Denver Health and Hospital Authority 2014-04-30
NCT01493778 Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A https://ClinicalTrials.gov/show/NCT01493778 Completed Novo Nordisk A/S 2017-08-16
NCT01487837 Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study. https://ClinicalTrials.gov/show/NCT01487837 Completed University Children’s Hospital, Zurich 2014-10-31
NCT01480180 Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A https://ClinicalTrials.gov/show/NCT01480180 Completed Novo Nordisk A/S 2018-12-10
NCT01467427 Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B. https://ClinicalTrials.gov/show/NCT01467427 Active, not recruiting Novo Nordisk A/S 2014-03-30
NCT01435304 The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass https://ClinicalTrials.gov/show/NCT01435304 Completed Maine Medical Center 2014-12-31
NCT01395810 Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773 https://ClinicalTrials.gov/show/NCT01395810 Completed Novo Nordisk A/S 2014-03-30
NCT01392547 Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors https://ClinicalTrials.gov/show/NCT01392547 Completed Novo Nordisk A/S 2012-08-31
NCT01386528 Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B https://ClinicalTrials.gov/show/NCT01386528 Completed Novo Nordisk A/S 2013-12-01
NCT01365520 A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A https://ClinicalTrials.gov/show/NCT01365520 Completed Novo Nordisk A/S 2011-09-30
NCT01333111 Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients https://ClinicalTrials.gov/show/NCT01333111 Completed Novo Nordisk A/S 2013-03-31
NCT04444700 A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04444700 Recruiting University of Sao Paulo General Hospital 2020-10-31
NCT04362085 Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care https://ClinicalTrials.gov/show/NCT04362085 Recruiting St. Michael’s Hospital, Toronto 2020-11-30
NCT04360824 Covid-19 Associated Coagulopathy https://ClinicalTrials.gov/show/NCT04360824 Recruiting University of Iowa 2021-04-16
NCT04309084 Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma https://ClinicalTrials.gov/show/NCT04309084 Recruiting Celularity Incorporated 2023-03-12
NCT04188171 Sclerotherapy With Polidocanol Foam In The Treatment Of Hemorrhoidal Disease In Patients With Bleeding Disorders https://ClinicalTrials.gov/show/NCT04188171 Recruiting Universidade do Porto 2020-02-01
NCT04140812 Stratifying Risk for Intracerebral Haemorrhage https://ClinicalTrials.gov/show/NCT04140812 Recruiting University of Erlangen-Nürnberg Medical School 2020-09-30
NCT04121767 Safety and Efficacy of Edoxaban in Thoracoscopic Ablation https://ClinicalTrials.gov/show/NCT04121767 Recruiting Samsung Medical Center 2020-06-30
NCT04074980 Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test https://ClinicalTrials.gov/show/NCT04074980 Completed LumiraDx UK Limited 2019-07-30
NCT04046029 Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention. https://ClinicalTrials.gov/show/NCT04046029 Recruiting The First Affiliated Hospital of Dalian Medical University 2020-07-30
NCT03815175 XIENCE 28 USA Study https://ClinicalTrials.gov/show/NCT03815175 Active, not recruiting Abbott Medical Devices 2020-12-31
NCT03756948 Viscoelastic Tests-Guided Therapy In Liver Transplantation https://ClinicalTrials.gov/show/NCT03756948 Completed Hospital Israelita Albert Einstein 2015-10-30
NCT03734588 Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors https://ClinicalTrials.gov/show/NCT03734588 Active, not recruiting Spark Therapeutics 2020-05-31
NCT03700723 Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy https://ClinicalTrials.gov/show/NCT03700723 Active, not recruiting Entegrion, Inc. 2020-12-31
NCT03666650 NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03666650 Completed Turku University Hospital 2019-01-08
NCT03616808 Thromboelastometry-identified Haemostatic Changes in Isolated Traumatic Brain Injury https://ClinicalTrials.gov/show/NCT03616808 Recruiting Lithuanian University of Health Sciences 2020-08-30
NCT03570281 Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study) https://ClinicalTrials.gov/show/NCT03570281 Recruiting Samsung Medical Center 2020-05-31
NCT03520712 Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5 https://ClinicalTrials.gov/show/NCT03520712 Enrolling by invitation BioMarin Pharmaceutical 2025-06-30
NCT03449342 Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period https://ClinicalTrials.gov/show/NCT03449342 Completed Novo Nordisk A/S 2019-03-25
NCT03444324 Adjusted Fibrinogen Replacement Strategy https://ClinicalTrials.gov/show/NCT03444324 Recruiting Biotest 2020-01-31
NCT01253811 Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency https://ClinicalTrials.gov/show/NCT01253811 Completed Novo Nordisk A/S 2015-03-31
NCT01238367 A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543 https://ClinicalTrials.gov/show/NCT01238367 Completed Novo Nordisk A/S 2011-10-31
NCT01230021 Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit Deficiency https://ClinicalTrials.gov/show/NCT01230021 Completed Novo Nordisk A/S 2012-01-31
NCT01228669 Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B https://ClinicalTrials.gov/show/NCT01228669 Completed Novo Nordisk A/S 2012-09-10
NCT01205724 Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A https://ClinicalTrials.gov/show/NCT01205724 Completed Novo Nordisk A/S 2011-04-30
NCT01187225 Fibrinogen Concentrate In Children After Cardiac Surgery https://ClinicalTrials.gov/show/NCT01187225 Completed University of Sao Paulo 2011-01-31
NCT01153997 Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers https://ClinicalTrials.gov/show/NCT01153997 Completed Novo Nordisk A/S 2010-08-31
NCT01138501 Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A https://ClinicalTrials.gov/show/NCT01138501 Completed Novo Nordisk A/S 2011-11-30
NCT01082406 Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT01082406 Completed Novo Nordisk A/S 2010-07-31
NCT03871452 The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding https://ClinicalTrials.gov/show/NCT03871452 Completed Haydarpasa Numune Training and Research Hospital 2018-10-11
NCT01029340 Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A https://ClinicalTrials.gov/show/NCT01029340 Completed Bayer 2012-06-30
NCT00994045 Fibrinogen as an Alternative to FFP in Aortic Surgery. https://ClinicalTrials.gov/show/NCT00994045 Completed University of Edinburgh 2013-08-31
NCT00984126 Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015 https://ClinicalTrials.gov/show/NCT00984126 Completed Novo Nordisk A/S 2016-06-28
NCT00978380 Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725 https://ClinicalTrials.gov/show/NCT00978380 Completed Novo Nordisk A/S 2015-10-20
NCT00966290 Anticoagulant Clinics and Vitamin K Antagonists https://ClinicalTrials.gov/show/NCT00966290 Completed University Hospital, Toulouse 2006-12-31
NCT00956345 Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B https://ClinicalTrials.gov/show/NCT00956345 Completed Novo Nordisk A/S 2010-07-31
NCT00951873 A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT00951873 Completed Novo Nordisk A/S 2010-04-30
NCT00951405 Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors https://ClinicalTrials.gov/show/NCT00951405 Completed Novo Nordisk A/S 2011-03-29
NCT00945542 The Trauma- Formula-Driven Versus Lab-Guided Study (TRFL Study) https://ClinicalTrials.gov/show/NCT00945542 Completed Sunnybrook Health Sciences Centre 2011-12-31
NCT00964353 Clinical and Economic Implications of Genetic Testing for Warfarin Management https://ClinicalTrials.gov/show/NCT00964353 Completed University of Chicago 2012-08-31
NCT00922792 Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B https://ClinicalTrials.gov/show/NCT00922792 Completed Novo Nordisk A/S 2009-09-30
NCT00914589 Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery https://ClinicalTrials.gov/show/NCT00914589 Completed Novo Nordisk A/S 2011-02-28
NCT00904709 The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders https://ClinicalTrials.gov/show/NCT00904709 Completed Nova Scotia Health Authority 2014-03-01
NCT00868309 A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab, https://ClinicalTrials.gov/show/NCT00868309 Completed Instituto Bioclon S.A. de C.V. 2006-08-31
NCT00840086 Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects https://ClinicalTrials.gov/show/NCT00840086 Completed Novo Nordisk A/S 2011-09-30
NCT02938585 Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A https://ClinicalTrials.gov/show/NCT02938585 Completed Novo Nordisk A/S 2018-03-16
NCT01143909 Transfusion of Fresh Frozen Plasma in Non-bleeding Intensive Care Unit (ICU) Patients https://ClinicalTrials.gov/show/NCT01143909 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2013-06-30
NCT00837356 Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects https://ClinicalTrials.gov/show/NCT00837356 Completed Novo Nordisk A/S 2009-10-31
NCT00822185 Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT00822185 Completed Novo Nordisk A/S 2009-07-31
NCT03826043 THrombo-Embolic Event in Onco-hematology https://ClinicalTrials.gov/show/NCT03826043 Recruiting Centre Antoine Lacassagne 2022-03-08
NCT03232398 Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus https://ClinicalTrials.gov/show/NCT03232398 Recruiting Hadassah Medical Organization 2020-07-31
NCT01949792 A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors https://ClinicalTrials.gov/show/NCT01949792 Completed Novo Nordisk A/S 2013-11-30
NCT00816127 Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction https://ClinicalTrials.gov/show/NCT00816127 Completed Icahn School of Medicine at Mount Sinai 2007-05-31
NCT01562457 Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State https://ClinicalTrials.gov/show/NCT01562457 Completed Novo Nordisk A/S 2006-04-30
NCT01489111 Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A. https://ClinicalTrials.gov/show/NCT01489111 Completed Novo Nordisk A/S 2018-12-10
NCT02137850 Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A https://ClinicalTrials.gov/show/NCT02137850 Enrolling by invitation Novo Nordisk A/S 2021-11-13
NCT02822599 Human Fibrinogen Concentrate in Pediatric Cardiac Surgery https://ClinicalTrials.gov/show/NCT02822599 Completed Nicklaus Children’s Hospital f/k/a Miami Children’s Hospital 2019-08-26
NCT03528551 A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A https://ClinicalTrials.gov/show/NCT03528551 Active, not recruiting Novo Nordisk A/S 2020-12-03
NCT03884725 Fibrinogen Concentrate In Children Cardiac Surgery 2 https://ClinicalTrials.gov/show/NCT03884725 Recruiting Instituto do Coracao 2019-06-30
NCT00803101 An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure https://ClinicalTrials.gov/show/NCT00803101 Completed CSL Behring 2012-11-30
NCT00713648 Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency https://ClinicalTrials.gov/show/NCT00713648 Completed Novo Nordisk A/S 2010-04-30
NCT00708435 Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy https://ClinicalTrials.gov/show/NCT00708435 Completed CSL Behring 2010-11-30
NCT00697385 The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders https://ClinicalTrials.gov/show/NCT00697385 Completed Mary M. Gooley Hemophilia Center 2008-06-30
NCT00571584 High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors https://ClinicalTrials.gov/show/NCT00571584 Completed Novo Nordisk A/S 2004-03-31
NCT00493272 Dilutional Coagulopathy in Patients Undergoing Elective Surgery https://ClinicalTrials.gov/show/NCT00493272 Completed University of Aarhus 2008-04-30
NCT00486278 Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds https://ClinicalTrials.gov/show/NCT00486278 Completed Novo Nordisk A/S 2010-06-30
NCT00426803 Recombinant Factor VIIa in Acute Intracerebral Haemorrhage https://ClinicalTrials.gov/show/NCT00426803 Completed Novo Nordisk A/S 2004-06-30
NCT00355290 Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial https://ClinicalTrials.gov/show/NCT00355290 Completed Hospital de Clinicas de Porto Alegre NA
NCT00266006 Factor VIIa in Acute Intracerebral Haemorrhage https://ClinicalTrials.gov/show/NCT00266006 Completed Novo Nordisk A/S 2007-04-30
NCT00212485 Study to Evaluate the Use of Ultrasound in the Diagnosis of Hemophilic Joint Disease https://ClinicalTrials.gov/show/NCT00212485 Completed New York Presbyterian Hospital 2008-04-30
NCT00188747 Comparison of Three Management Strategies for Post Cardiac Surgery Bleeding https://ClinicalTrials.gov/show/NCT00188747 Completed University Health Network, Toronto NA
NCT00168090 Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) https://ClinicalTrials.gov/show/NCT00168090 Completed CSL Behring NA
NCT00154492 Use of NovoSeven® in Active Variceal Bleeding https://ClinicalTrials.gov/show/NCT00154492 Completed Novo Nordisk A/S 2006-08-31
NCT00143715 Oral Vitamin K for Warfarin Associated Coagulopathy https://ClinicalTrials.gov/show/NCT00143715 Completed St. Joseph’s Healthcare Hamilton 2006-10-31
NCT00127283 Recombinant Factor VIIa in Acute Intracerebral Haemorrhage https://ClinicalTrials.gov/show/NCT00127283 Completed Novo Nordisk A/S 2007-01-31
NCT00123591 Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury https://ClinicalTrials.gov/show/NCT00123591 Completed Novo Nordisk A/S 2006-05-31
NCT00111215 Treatment and Management of Women With Bleeding Disorders https://ClinicalTrials.gov/show/NCT00111215 Completed Centers for Disease Control and Prevention NA
NCT00108797 Trial of NovoSeven® in Haemophilia - Joint Bleeds https://ClinicalTrials.gov/show/NCT00108797 Completed Novo Nordisk A/S 2006-02-28
NCT00108758 Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia https://ClinicalTrials.gov/show/NCT00108758 Completed Novo Nordisk A/S 2005-11-30
NCT00104455 Dose Response to Recombinant Factor VIIa When Administered for Bleed https://ClinicalTrials.gov/show/NCT00104455 Completed Novo Nordisk A/S 2004-11-30
NCT00102037 Use of Activated Recombinant FVII in Spinal Surgery https://ClinicalTrials.gov/show/NCT00102037 Completed Novo Nordisk A/S 2006-02-28
NCT00056589 Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency https://ClinicalTrials.gov/show/NCT00056589 Completed Novo Nordisk A/S 2003-10-31
NCT00000582 Cooperative Study of Factor VIII Inhibitors https://ClinicalTrials.gov/show/NCT00000582 Completed National Heart, Lung, and Blood Institute (NHLBI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04278404 Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) https://ClinicalTrials.gov/show/NCT04278404 Recruiting Duke University 2024-04-24
NCT03871283 Anticoagulation and Antiplatelet Management During Perioperative Period https://ClinicalTrials.gov/show/NCT03871283 Recruiting Erasme University Hospital 2019-12-31
NCT03292666 Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study https://ClinicalTrials.gov/show/NCT03292666 Recruiting University of California, San Francisco 2020-12-31
NCT03280368 Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation https://ClinicalTrials.gov/show/NCT03280368 Completed Hospitalsenheden Vest 2019-11-30
NCT03275077 To Compare TEG (Thrombelastography) and Conventional Tests in CKD Patients https://ClinicalTrials.gov/show/NCT03275077 Completed Institute of Liver and Biliary Sciences, India 2016-12-22
NCT03267823 INR Comparison Testing in Cardiac Surgery https://ClinicalTrials.gov/show/NCT03267823 Completed University of Miami 2019-03-21
NCT03195543 Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03195543 Recruiting National and Kapodistrian University of Athens 2020-12-31
NCT03179748 Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients https://ClinicalTrials.gov/show/NCT03179748 Enrolling by invitation Novo Nordisk A/S 2021-06-28
NCT03168087 Plasmalyte-148 Solution and Blood Coagulation https://ClinicalTrials.gov/show/NCT03168087 Completed Seoul National University Hospital 2018-08-23
NCT03128658 Trauma Induced Coagulopathy and Inflammation https://ClinicalTrials.gov/show/NCT03128658 Recruiting University of Pennsylvania 2020-12-31
NCT03112525 DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic https://ClinicalTrials.gov/show/NCT03112525 Recruiting University Hospital, Geneva 2020-04-30
NCT03105180 Irrigating Fluid and Blood Coagulation https://ClinicalTrials.gov/show/NCT03105180 Completed Seoul National University Bundang Hospital 2017-03-29
NCT02991066 Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia https://ClinicalTrials.gov/show/NCT02991066 Recruiting First Affiliated Hospital of Harbin Medical University 2019-12-31
NCT02884999 Management of Bleeding and Coagulopathy in Trauma and Compliance to European Trauma Guidelines https://ClinicalTrials.gov/show/NCT02884999 Completed University Hospital, Brest 2015-11-30
NCT02856789 Determination of Fibrin Activity in Plasma on STA-R® Prototype https://ClinicalTrials.gov/show/NCT02856789 Recruiting Diagnostica Stago R&D 2019-03-31
NCT02670213 A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan https://ClinicalTrials.gov/show/NCT02670213 Enrolling by invitation Novo Nordisk A/S 2024-09-30
NCT02652897 Hemostasis Alterations in Neurosurgical Patients https://ClinicalTrials.gov/show/NCT02652897 Recruiting Hospitales Universitarios Virgen del Rocío 2019-02-28
NCT02035384 Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A https://ClinicalTrials.gov/show/NCT02035384 Completed Novo Nordisk A/S 2020-01-15
NCT02540005 Coagulation Disorders After Aneurysmatic Subarachnoid Haemorrhage https://ClinicalTrials.gov/show/NCT02540005 Completed Tampere University Hospital 2016-06-30
NCT02422810 High-Shear Microfluidic Thrombosis Assay https://ClinicalTrials.gov/show/NCT02422810 Completed Emory University 2015-10-31
NCT02387944 Bedside Evaluation of Coagulation in Children With Congenital Heart Disease https://ClinicalTrials.gov/show/NCT02387944 Completed Centre Hospitalier Universitaire Vaudois 2017-07-06
NCT02352805 Coagulopathy and SIRS During ECC in Intensive Care https://ClinicalTrials.gov/show/NCT02352805 Active, not recruiting University Hospital Tuebingen 2020-12-31
NCT02329899 Standardisation of Investigations of Mild Bleeding Disorders https://ClinicalTrials.gov/show/NCT02329899 Completed University Hospital, Geneva 2016-09-30
NCT02241694 To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives https://ClinicalTrials.gov/show/NCT02241694 Completed Novo Nordisk A/S 2015-07-31
NCT02207218 To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan https://ClinicalTrials.gov/show/NCT02207218 Active, not recruiting Novo Nordisk A/S 2021-02-04
NCT02132208 Evaluation of the TICCS Capacity to Identify Trauma Patients With Acute Coagulopathy and Massive Bleeding https://ClinicalTrials.gov/show/NCT02132208 Completed Centre Hospitalier Régional de la Citadelle 2013-06-30
NCT02086682 A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients https://ClinicalTrials.gov/show/NCT02086682 Completed Mayo Clinic 2015-08-31
NCT02083549 Evaluating URMC’s Massive Transfusion Protocol https://ClinicalTrials.gov/show/NCT02083549 Completed University of Rochester 2014-12-16
NCT01312636 Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII Deficiency https://ClinicalTrials.gov/show/NCT01312636 Completed Novo Nordisk A/S 2014-09-30
NCT01285089 Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia https://ClinicalTrials.gov/show/NCT01285089 Completed Novo Nordisk A/S 2013-10-31
NCT01280825 The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing https://ClinicalTrials.gov/show/NCT01280825 Recruiting University of Chicago 2020-11-14
NCT04219371 Reference Range Study for the Quantra QStat System https://ClinicalTrials.gov/show/NCT04219371 Completed HemoSonics LLC 2020-04-17
NCT01988532 Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia https://ClinicalTrials.gov/show/NCT01988532 Completed Novo Nordisk A/S 2014-10-31
NCT01959555 Project to Update the Study of Congenital Haemophilia in Spain https://ClinicalTrials.gov/show/NCT01959555 Completed Novo Nordisk A/S 2014-12-31
NCT01882114 Atherosclerosis in Atrial Fibrillation https://ClinicalTrials.gov/show/NCT01882114 Recruiting University of Roma La Sapienza 2020-12-31
NCT01876745 A Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann’s Thrombasthenia in Japan https://ClinicalTrials.gov/show/NCT01876745 Completed Novo Nordisk A/S 2017-06-01
NCT01862367 Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study https://ClinicalTrials.gov/show/NCT01862367 Completed Novo Nordisk A/S 2019-06-26
NCT01779921 Treatment of Congenital Factor VII Deficiency https://ClinicalTrials.gov/show/NCT01779921 Completed Novo Nordisk A/S 2012-01-31
NCT01727830 Hemodilution and Coagulopathy With 3 Colloids https://ClinicalTrials.gov/show/NCT01727830 Completed University of Zurich 2012-11-30
NCT04356950 Analysis of the Coagulopathy Developed by COVID-19 Infected Patients https://ClinicalTrials.gov/show/NCT04356950 Recruiting Centre Hospitalier Universitaire de Nīmes 2020-10-31
NCT01638481 Chronology of Occult and Gross Coagulopathy in Burn Patients https://ClinicalTrials.gov/show/NCT01638481 Active, not recruiting Medstar Health Research Institute 2017-03-31
NCT01589172 Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury https://ClinicalTrials.gov/show/NCT01589172 Completed University of California, San Diego 2012-11-30
NCT01586936 Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors https://ClinicalTrials.gov/show/NCT01586936 Completed Novo Nordisk A/S 2010-03-09
NCT01579968 Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery https://ClinicalTrials.gov/show/NCT01579968 Completed Novo Nordisk A/S 2010-03-09
NCT01579955 Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice https://ClinicalTrials.gov/show/NCT01579955 Completed Novo Nordisk A/S 2010-03-09
NCT01503567 Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries https://ClinicalTrials.gov/show/NCT01503567 Completed Novo Nordisk A/S 2012-09-30
NCT01476423 Observational Registry of the Treatment of Glanzmann’s Thrombasthenia https://ClinicalTrials.gov/show/NCT01476423 Completed Novo Nordisk A/S 2011-10-31
NCT01375725 Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood https://ClinicalTrials.gov/show/NCT01375725 Completed Universal Biosensors Pty Ltd 2010-09-30
NCT01322620 Survey Evaluating the Psychosocial Effects of Living With Haemophilia https://ClinicalTrials.gov/show/NCT01322620 Completed Novo Nordisk A/S 2012-02-29
NCT04356144 Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections https://ClinicalTrials.gov/show/NCT04356144 Recruiting Medical University of Vienna 2020-10-01
NCT04322721 Coagulopathy on the First Postoperative Day Predicts the Long-term Survival of Traumatic Brain Injury Patients https://ClinicalTrials.gov/show/NCT04322721 Completed Tang-Du Hospital 2020-01-31
NCT04274777 The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders https://ClinicalTrials.gov/show/NCT04274777 Recruiting Tang-Du Hospital 2020-09-21
NCT04269278 Dexmedetomidine and Blood Coagulation https://ClinicalTrials.gov/show/NCT04269278 Recruiting Seoul National University Bundang Hospital 2020-12-12
NCT04265508 Assessment of Hemostatic Profile in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04265508 Completed Goethe University 2018-05-01
NCT03347591 Rare Bleeding Disorders in the Netherlands https://ClinicalTrials.gov/show/NCT03347591 Recruiting Radboud University 2020-12-01
NCT04190615 Determination of ClotPro Paediatric Reference Range Study https://ClinicalTrials.gov/show/NCT04190615 Recruiting National Institute of Children’s Diseases, Slovakia 2020-12-31
NCT04159064 Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices https://ClinicalTrials.gov/show/NCT04159064 Completed AHEPA University Hospital 2019-04-30
NCT04111120 Heparin Like Effect in Acute Variceal Bleeding https://ClinicalTrials.gov/show/NCT04111120 Recruiting Postgraduate Institute of Medical Education and Research 2020-12-31
NCT04076605 Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive Procedures https://ClinicalTrials.gov/show/NCT04076605 Recruiting University of Virginia 2020-11-01
NCT03890016 Study Comparing Modified Lee White Clotting Time Against Twenty Minute Whole Blood Clotting Test in Snakebite Victims https://ClinicalTrials.gov/show/NCT03890016 Recruiting Jubilee Mission Medical College and Research Institute 2020-05-31
NCT03882593 Blood Cell Adhesion to Arterial Filters During Cardiac Surgery https://ClinicalTrials.gov/show/NCT03882593 Recruiting Instituto do Coracao 2019-05-31
NCT03876301 Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants https://ClinicalTrials.gov/show/NCT03876301 Active, not recruiting Spark Therapeutics 2020-07-31
NCT03699813 ROTEM Versus aPTT/PT in Pediatric Surgery https://ClinicalTrials.gov/show/NCT03699813 Completed University Hospital, Motol 2018-09-15
NCT03685097 Comparison of Two Point-of-care Devices for Viscoelastic Hemostasis Assays https://ClinicalTrials.gov/show/NCT03685097 Completed HemoSonics LLC 2018-07-31
NCT03572309 Incidence of Trauma Induced Coagulopathy in Patients With Prehospital Administration of Fibrinogen https://ClinicalTrials.gov/show/NCT03572309 Recruiting Masaryk University 2020-07-31
NCT03555630 Thromboelastogram in Postdelivery Preeclamptic Patients https://ClinicalTrials.gov/show/NCT03555630 Completed Augusta University 2019-10-31
NCT03555383 Individualized Multimodal Hemostasis Evaluation Pyramid (IMHOTEP) https://ClinicalTrials.gov/show/NCT03555383 Recruiting Semmelweis University 2020-02-01
NCT03482128 Blood Transfusion and Postoperative Outcome Before and After Implementing a Coagulation Management Algorithm https://ClinicalTrials.gov/show/NCT03482128 Completed Triemli Hospital 2015-12-31
NCT03475940 Coagulopathy in Cardiac Surgery https://ClinicalTrials.gov/show/NCT03475940 Recruiting Mahidol University 2019-06-30
NCT03468738 Investigation of the Transfusion Practices in Surgical Patients in Turkey https://ClinicalTrials.gov/show/NCT03468738 Completed Diskapi Teaching and Research Hospital 2019-02-01
NCT01234545 Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors https://ClinicalTrials.gov/show/NCT01234545 Completed Novo Nordisk A/S 2012-04-30
NCT01228058 A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients https://ClinicalTrials.gov/show/NCT01228058 Completed The University of Texas Health Science Center, Houston 2012-01-31
NCT01220141 Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B https://ClinicalTrials.gov/show/NCT01220141 Completed Novo Nordisk A/S 2015-03-31
NCT00998647 Modified Ultrafiltration in Cardiac Surgery https://ClinicalTrials.gov/show/NCT00998647 Completed Goethe University 2010-04-30
NCT00882778 PROPACT: Retrospective Prophylaxis Patient Case Collection https://ClinicalTrials.gov/show/NCT00882778 Completed Novo Nordisk A/S 2010-05-31
NCT00853086 Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database https://ClinicalTrials.gov/show/NCT00853086 Completed Novo Nordisk A/S 2011-06-30
NCT02568202 Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S) https://ClinicalTrials.gov/show/NCT02568202 Completed Novo Nordisk A/S 2015-11-30
NCT00969319 Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America https://ClinicalTrials.gov/show/NCT00969319 Completed Bayer 2013-02-28
NCT01830712 A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors https://ClinicalTrials.gov/show/NCT01830712 Completed Novo Nordisk A/S 2011-08-31
NCT01604083 European Transfusion Practice and Outcome Study https://ClinicalTrials.gov/show/NCT01604083 Completed European Society of Anaesthesiology 2013-10-31
NCT04267406 ADAMTS-13 and Von Willebrand Factor Levels and Activities in Children With Cirrhosis and/or Portal Hypertension https://ClinicalTrials.gov/show/NCT04267406 Completed Ataturk University 2019-10-30
NCT03391622 Thrombin Generation Values and Percutaneous Coronary Intervention Results. https://ClinicalTrials.gov/show/NCT03391622 Recruiting HaEmek Medical Center, Israel 2019-08-30
NCT04107818 Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients. https://ClinicalTrials.gov/show/NCT04107818 Recruiting Masaryk University 2020-08-01
NCT03674684 ROTEM Assessment of Modern Crystalloid, Hydroxyethyl Starch and Gelatin Effect on Coagulation https://ClinicalTrials.gov/show/NCT03674684 Completed University Hospital, Motol 2018-07-14
NCT00782470 Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A https://ClinicalTrials.gov/show/NCT00782470 Completed Bayer 2010-11-30
NCT00772434 Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument https://ClinicalTrials.gov/show/NCT00772434 Completed Rockefeller University 2011-05-31
NCT00710619 Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX https://ClinicalTrials.gov/show/NCT00710619 Completed Novo Nordisk A/S 2009-07-31
NCT00703911 Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors https://ClinicalTrials.gov/show/NCT00703911 Completed Novo Nordisk A/S 2010-07-31
NCT00697320 Observational Study on the Efficacy and Safety of NovoSeven® During “Real-life” Usage in Germany https://ClinicalTrials.gov/show/NCT00697320 Completed Novo Nordisk A/S 2010-12-31
NCT00522002 CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study https://ClinicalTrials.gov/show/NCT00522002 Completed George Washington University 2010-06-30
NCT00516126 Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery https://ClinicalTrials.gov/show/NCT00516126 Completed University Hospital, Basel, Switzerland 2011-12-31
NCT00210197 Hypercoagulability After Breast Cancer Surgery https://ClinicalTrials.gov/show/NCT00210197 Completed Institut Bergonié NA
NCT00165906 Thrombin Generation in Neonates https://ClinicalTrials.gov/show/NCT00165906 Completed Emory University 2009-01-31
NCT00124293 Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury https://ClinicalTrials.gov/show/NCT00124293 Completed Novo Nordisk A/S 2005-11-23
NCT00091494 Socioeconomic Patterning of Inflammation and Hemostasis - Ancillary to MESA https://ClinicalTrials.gov/show/NCT00091494 Completed University of Michigan 2008-06-30
NCT00086476 Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles https://ClinicalTrials.gov/show/NCT00086476 Completed National Institutes of Health Clinical Center (CC) NA
NCT00063518 Monitoring Trends in Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00063518 Completed University of Massachusetts, Worcester 2007-12-31
NCT00005481 Epidemiology of Impaired Coagulant Balance in Diabetes https://ClinicalTrials.gov/show/NCT00005481 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00001927 Study of Abnormal Blood Clotting in Children With Stroke https://ClinicalTrials.gov/show/NCT00001927 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03255928 Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD) https://ClinicalTrials.gov/show/NCT03255928 Recruiting Scientific Institute San Raffaele 2020-06-29
NCT02813538 Major Liver Resection: Early Clotting Disorders and Functional Impairment. https://ClinicalTrials.gov/show/NCT02813538 Completed Hospital General Universitario Gregorio Marañon 2018-10-31
NCT02776826 World Bleeding Disorders Registry Pilot Study https://ClinicalTrials.gov/show/NCT02776826 Completed World Federation of Hemophilia 2016-12-31
NCT02720679 Investigation of the Genetics of Hematologic Diseases https://ClinicalTrials.gov/show/NCT02720679 Recruiting St. Jude Children’s Research Hospital 2026-08-31
NCT02512250 Swiss Hemophilia Registry https://ClinicalTrials.gov/show/NCT02512250 Recruiting Swiss Hemophilia Network 2025-12-31
NCT04329390 MAC Project, Monitoring of AntiCoagulant Therapies (MAC) https://ClinicalTrials.gov/show/NCT04329390 Recruiting Quovadis Associazione 2024-03-01
NCT04201860 Blood Gas and Bleeding Disorders in Healthy Volunteers Exposed to Nitroglycerin and Nitrogen Compounds https://ClinicalTrials.gov/show/NCT04201860 Completed San Salvatore Hospital of L’Aquila 2018-11-12
NCT03956836 Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC) https://ClinicalTrials.gov/show/NCT03956836 Recruiting Hospitales Universitarios Virgen del Rocío 2020-10-31
NCT03834727 Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders https://ClinicalTrials.gov/show/NCT03834727 Enrolling by invitation Oregon Health and Science University 2021-09-04
NCT03647644 Coagulation Test Changes Associated With Acute Normovolemic Hemodilution in Cardiac Surgery https://ClinicalTrials.gov/show/NCT03647644 Completed Mayo Clinic 2018-10-11
NCT02279199 Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM) https://ClinicalTrials.gov/show/NCT02279199 Active, not recruiting Oregon Health and Science University 2022-01-31
NCT03760874 Atrial Fibrillation Research Database https://ClinicalTrials.gov/show/NCT03760874 Recruiting University of Campania “Luigi Vanvitelli” 2022-01-01